4218 Stock Overview
Develops, manufactures, and sells medical products and tapes in Asia and Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for 4218 from our risk checks.
Nichiban Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,925.00 |
| 52 Week High | JP¥2,064.00 |
| 52 Week Low | JP¥1,680.00 |
| Beta | 0.23 |
| 11 Month Change | -0.26% |
| 3 Month Change | -2.38% |
| 1 Year Change | 9.87% |
| 33 Year Change | 3.94% |
| 5 Year Change | 1.96% |
| Change since IPO | 41.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4218 | JP Commercial Services | JP Market | |
|---|---|---|---|
| 7D | 1.0% | -3.3% | -0.4% |
| 1Y | 9.9% | 9.6% | 11.4% |
Return vs Industry: 4218 matched the JP Commercial Services industry which returned 9.6% over the past year.
Return vs Market: 4218 underperformed the JP Market which returned 11.4% over the past year.
Price Volatility
| 4218 volatility | |
|---|---|
| 4218 Average Weekly Movement | 2.4% |
| Commercial Services Industry Average Movement | 3.4% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 7.6% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 4218 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4218's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1918 | 1,270 | Toshiaki Takatsu | www.nichiban.co.jp |
Nichiban Co., Ltd. develops, manufactures, and sells medical products and tapes in Asia and Europe. It offers medical products, including surgical tapes, wound care dressing tapes, post-operative care tapes, cornea protection tapes, and hemostatic and first-aid bandages; and sports tapes, underwraps, scissors, and bags. The company also provides curative drug for corns, calluses, and warts; Navel Compression pack, which is used for umbilical hernia compression treatment in infants; and fabric plasters, permeable film and puncture site protection dressings, absorbent hemostatic pressure dressings, and non-woven surgical tapes.
Nichiban Co., Ltd. Fundamentals Summary
| 4218 fundamental statistics | |
|---|---|
| Market cap | JP¥39.19b |
| Earnings (TTM) | JP¥2.20b |
| Revenue (TTM) | JP¥48.16b |
17.8x
P/E Ratio0.8x
P/S RatioIs 4218 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4218 income statement (TTM) | |
|---|---|
| Revenue | JP¥48.16b |
| Cost of Revenue | JP¥33.47b |
| Gross Profit | JP¥14.69b |
| Other Expenses | JP¥12.48b |
| Earnings | JP¥2.20b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 108.26 |
| Gross Margin | 30.50% |
| Net Profit Margin | 4.58% |
| Debt/Equity Ratio | 4.8% |
How did 4218 perform over the long term?
See historical performance and comparisonDividends
1.8%
Current Dividend Yield32%
Payout RatioDoes 4218 pay a reliable dividends?
See 4218 dividend history and benchmarks| Nichiban dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 27 2025 |
| Days until Ex dividend | 126 days |
| Days until Dividend pay date | 217 days |
Does 4218 pay a reliable dividends?
See 4218 dividend history and benchmarks